Crossmark

Assessing viability of a minimally invasive autopsy technique in ascertaining the probable cause of death in patients who were SARS CoV19 positive at the time of their demise

Crossref DOI link: https://doi.org/10.1186/s42047-021-00094-3

Published Online: 2021-07-13

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bhandarwar, Ajay H.

Bakhshi, Girish D.

Arora, Eham

Dhimole, Nikhil https://orcid.org/0000-0003-4899-7121
Bijwe, Sanjay R.

Agale, Shubhangi V.

Kinake, Megha S.

Domkundwar, Shilpa

Thube, Yogesh
License Information

Text and Data Mining valid from 2021-07-13

Version of Record valid from 2021-07-13
More Information

Article History

Received: 29 January 2021

Accepted: 8 June 2021

First Online: 13 July 2021

Declarations

:

: Approval from Institutional Ethics Committee was obtained with ref. no. IEC/Pharm/RP/134/Jul/2020 on 15/07/2020.

: The consent for autopsy technique was obtained from the deceased’s next of kin.

: Dr. Eham Arora has received honoraria for speaking engagements from Johnson & Johnson India Pvt. Ltd. He is a partner in HerniaCAT Surgical Radiology Inc.The other co-authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below